Anterior pituitary gland synthesises dopamine from l-3,4-dihydroxyphenylalanine (l-dopa).
AtT20 cells
GH3 cells
anterior pituitary
aromatic l-amino acid decarboxylase
dopamine
l-dopa
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
14
02
2020
revised:
08
05
2020
accepted:
11
06
2020
pubmed:
17
7
2020
medline:
26
10
2021
entrez:
17
7
2020
Statut:
ppublish
Résumé
Prolactin (PRL) is a hormone principally secreted by lactotrophs of the anterior pituitary gland. Although the synthesis and exocytosis of this hormone are mainly under the regulation of hypothalamic dopamine (DA), the possibility that the anterior pituitary synthesises this catecholamine remains unclear. The present study aimed to determine if the anterior pituitary produces DA from the precursor l-3,4-dihydroxyphenylalanine (l-dopa). Accordingly, we investigated the expression of aromatic l-amino acid decarboxylase (AADC) enzyme and the transporter vesicular monoamine transporter 2 (VMAT2) in the anterior pituitary, AtT20 and GH3 cells by immunofluorescence and western blotting. Moreover, we investigated the production of DA from l-dopa and its release in vitro. Then, we explored the effects of l-dopa with respect to the secretion of PRL from anterior pituitary fragments. We observed that the anterior pituitary, AtT20 and GH3 cells express both AADC and VMAT2. Next, we detected an increase in DA content after anterior pituitary fragments were incubated with l-dopa. Also, the presence of l-dopa increased DA levels in incubation media and reduced PRL secretion. Likewise, the content of cellular DA increased after AtT20 cells were incubated with l-dopa. In addition, l-dopa reduced corticotrophin-releasing hormone-stimulated adrenocorticotrophic hormone release from these cells after AADC activity was inhibited by NSD-1015. Moreover, DA formation from l-dopa increased apoptosis and decreased proliferation. However, in the presence of NSD-1015, l-dopa decreased apoptosis and increased proliferation rates. These results suggest that the anterior pituitary synthesises DA from l-dopa by AADC and this catecholamine can be released from this gland contributing to the control of PRL secretion. In addition, our results suggest that l-dopa exerts direct actions independently from its metabolisation to DA.
Substances chimiques
Levodopa
46627O600J
Adrenocorticotropic Hormone
9002-60-2
Prolactin
9002-62-4
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12885Informations de copyright
© 2020 British Society for Neuroendocrinology.
Références
Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523-1631.
Fitzgerald P, Dinan TG. Prolactin and dopamine: what is the connection? A review article. J Psychopharmacol. 2008;22(2 Suppl):12-19.
Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724-763.
Radl DB, Ferraris J, Boti V, Seilicovich A, Sarkar DK, Pisera D. Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PLoS ONE. 2011;6:e18097.
Radl DB, Zárate S, Jaita G, et al. Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. Neuroendocrinology. 2008;88:43-52.
Grattan DR. 60 years of neuroendocrinology: the hypothalamo-prolactin axis. J Endocrinol. 2015;226:T101-T122.
Ferraris J, Zarate S, Jaita G, Boutillon F, Bernadet M, Auffret J, et al. Prolactin induces apoptosis of lactotropes in female rodents. PLoS ONE. 2014;9:e97383.
Gasnier B. The loading of neurotransmitters into synaptic vesicles. Biochimie. 2000;82:327-337.
Meiser J, Weindl D, Hiller K. Complexity of dopamine metabolism. Cell Commun Signal. 2013;11:34.
Ugrumov MV. Brain neurons partly expressing dopaminergic phenotype: location, development, functional significance, and regulation. Adv Pharmacol. 2013;68:37-91.
Gibbs DM, Neill JD. Dopamine levels in hypophysial stalk blood in the rat are sufficient to inhibit prolactin secretion in vivo. Endocrinology. 1978;102:1895-1900.
Telford N, May PC, Sinha YN, Porter JC, Finch CE. Dopa accumulates in the hypothalamic-hypophysial portal vessels and is taken into the anterior pituitary of NSD-1015-treated rodents. Neuroendocrinology. 1992;55:390-395.
Jaubert A, Drutel G, Leste-Lasserre T, Ichas F, Bresson-Bepoldin L. Tyrosine hydroxylase and dopamine transporter expression in lactotrophs from postlactating rats: involvement in dopamine-induced apoptosis. Endocrinology. 2007;148:2698-2707.
Fernandez-Ruiz JJ, Esquifino AI, Steger RW, Amador AG, Bartke A. Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats. Brain Res. 1987;421:65-68.
Saavedra JM, Palkovits M, Kizer JS, Brownstein M, Zivin JA. Distribution of biogenic amines and related enzymes in the rat pituitary gland. J Neurochem. 1975;25:257-260.
Schussler N, Boularand S, Li JY, Peillon F, Mallet J, Biguet NF. Multiple tyrosine hydroxylase transcripts and immunoreactive forms in the rat: differential expression in the anterior pituitary and adrenal gland. J Neurosci Res. 1995;42:846-854.
Iturriza FC, Rubio MC, Gomez Dumm CL, Zieher LM. Catecholamine metabolizing enzymes and synthesis of dopamine in normal and grafted pituitary partes distales. Neuroendocrinology. 1983;37:371-377.
Johnston CA, Spinedi E, Negro-Vilar A. Aromatic L-amino acid decarboxylase activity in the rat median eminence, neurointermediate lobe and anterior lobe of the pituitary. Physiological and pharmacological implications for pituitary regulation. Neuroendocrinology. 1984;39:54-59.
Williams JC, Stone D, Smith-Arica JR, Morris ID, Lowenstein PR, Castro MG. Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppresses growth of estrogen-induced pituitary prolactinomas. Mol Ther. 2001;4:593-602.
Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci. 2006;26:193-202.
King JM, Muthian G, Mackey V, Smith M, Charlton C. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease. Life Sci. 2011;89:638-643.
Gong YY, Liu YY, Yu S, Zhu XN, Cao XP, Xiao HP. Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormone-producing pituitary adenoma. Mol Med Rep. 2014;9:2533-2539.
Jian F, Chen Y, Ning G, et al. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway. Oncotarget. 2016;7:9175-9187.
Jian F-F, Li Y-F, Chen Y-F, et al. Inhibition of ubiquitin-specific peptidase 8 suppresses adrenocorticotropic hormone production and tumorous corticotroph cell growth in AtT20 cells. Chin Med J (Engl). 2016;129:2102-2108.
Lim JS, Eom YW, Lee ES, et al. Effects of oxytocin on cell proliferation in a corticotroph adenoma cell line. Endocrinol Metab (Seoul). 2019;34:302-313.
Liu F, Khawaja X. Basal adrenocorticotropin (ACTH) secretion is negatively modulated by protein phosphatase 5 in mouse pituitary corticotropin AtT20 cells. Regul Pept. 2005;127:191-196.
Shida A, Ikeda T, Tani N, et al. Cortisol levels after cold exposure are independent of adrenocorticotropic hormone stimulation. PLoS One. 2020;15:e0218910.
Zhang C, Qiang Q, Jiang Y, et al. Effects of hypoxia inducible factor-1alpha on apoptotic inhibition and glucocorticoid receptor downregulation by dexamethasone in AtT-20 cells. BMC Endocr Disord. 2015;15:24.
Wolfe S, Morris S. Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels. J Neurochem. 2000;73:2375-2382.
Wolfe SE, Howard DE, Schetz JA, et al. Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathway. J Neurochem. 1999;72:479-490.
Fischberg D, Bancroft C. The D2 receptor: blocked transcription in GH3 cells and cellular pathways employed by D2A to regulate prolactin promoter activity. Mol Cell Endocrinol. 1995;111:129-137.
Gershengorn M, Hoffstein S, Rebecchi M, Geras E, Rubin B. Thyrotropin-releasing hormone stimulation of prolactin release from clonal rat pituitary cells. J Clin Investig. 1981;67:1769-1776.
Greene L, Tischler A. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976;73:2424-2428.
Enayah S, Vanle B, Fuortes L, Doorn J, Ludewig G. PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells. Toxicology. 2018;394:93-101.
Guillou A, Romanò N, Steyn F, et al. Assessment of lactotroph axis functionality in mice: longitudinal monitoring of PRL secretion by ultrasensitive-ELISA. Endocrinology. 2015;156:1924-1930.
Stansley BJ, Yamamoto BK. L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells. Neuropharmacology. 2013;67:243-251.
Jaubert A, Ichas F, Bresson-Bepoldin L. Signaling pathway involved in the pro-apoptotic effect of dopamine in the GH3 pituitary cell line. Neuroendocrinology. 2006;83:77-88.
Kamberi IA, Kobayashi Y. Monoamine oxidase activity in the hypothalamus and various other brain areas and in some endocrine glands of the rat during the estrus cycle. J Neurochem. 1970;17:261-268.
Kasuya E, Yayou K, Sutoh M. L-DOPA attenuates prolactin secretion in response to isolation stress in Holstein steers. Anim Sci J. 2013;84:562-568.
Prilusky J, Deis RP. Effect of L-dopa on milk ejection and prolactin release in lactating rats. J Endocrinol. 1975;67:397-401.
Richards GE, Holland FJ, Aubert ML, Ganong WF, Kaplan SL, Grumbach MM. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs. Neuroendocrinology. 1980;30:139-143.
Riegle GD, Meites J. Effects of aging on LH and prolactin after LHRL L-dopa, methyl-dopa, and stress in male rat. Proc Soc Exp Biol Med. 1976;151:507-511.
Watkins BE, McKay DW, Meites J, Riegle GD. L-Dopa effects on serum LH and prolactin in old and young female rats. Neuroendocrinology. 1975;19:331-338.
Ruggieri S, Falaschi P, Baldassarre M, et al. Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease. Neuropsychobiology. 1982;8:102-108.
Stypula G, Kunert-Radek J, Stepien H, Zylinska K, Pawlikowski M. Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with Parkinson's disease. Neuroimmunomodulation. 1996;3:131-134.
Garcia-Borreguero D, Larrosa O, Granizo JJ, de la Llave Y, Hening WA. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27:669-673.
Saito I, Kawabe H, Hasegawa C, et al. Effect of L-dopa in young patients with hypertension. Angiology. 1991;42:691-695.
Szabo M, Nakawatase C, Kovathana N, Frohman LA. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects. Neuroendocrinology. 1977;24:24-34.
Melnikova VI, Lyupina YV, Lavrentieva AV, Sapronova AY, Ugrumov MV. Synthesis of dopamine in non-dopaminergic neurons of the mediobasal hypothalamus of adult rats. Dokl Biol Sci. 2012;446:286-289.
Armando I, Villar VA, Jose PA. Dopamine and renal function and blood pressure regulation. Compr Physiol. 2011;1:1075-1117.
Horellou P, Guibert B, Leviel V, Mallet J. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc Natl Acad Sci USA. 1989;86:7233-7237.
Lipski J, Nistico R, Berretta N, Guatteo E, Bernardi G, Mercuri NB. L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease? Prog Neurogibol. 2011;94:389-407.
Oláh M, Fehér P, Ihm Z, et al. Dopamine-regulated adrenocorticotropic hormone secretion in lactating rats: functional plasticity of melanotropes. Neuroendocrinology. 2009;90:391-401.
Misu Y, Goshima Y, Miyamae T. Is DOPA a neurotransmitter? Trends Pharmacol Sci. 2002;23:262-268.
Goshima Y, Masukawa D, Kasahara Y, Hashimoto T, Aladeokin AC. l-DOPA and its receptor GPR143: implications for pathogenesis and therapy in Parkinson's disease. Front Pharmacol. 2019;10:1119.
Liedhegner EA, Steller KM, Mieyal JJ. Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease. Chem Res Toxicol. 2011;24:1644-1652.
Park KH, Park HJ, Shin KS, Lee MK. Multiple treatments with L-3,4-dihydroxyphenylalanine modulate dopamine biosynthesis and neurotoxicity through the protein kinase A-transient extracellular signal-regulated kinase and exchange protein activation by cyclic AMP-sustained extracellular signal-regulated kinase signaling pathways. J Neurosci Res. 2014;92:1746-1756.
Park KH, Shin KS, Zhao TT, Park HJ, Lee KE, Lee MK. L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells. Neuropharmacology. 2016;101:87-97.
Shin JY, Park HJ, Ahn YH, Lee PH. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. J Neurochem. 2009;111:1042-1050.
Stednitz SJ, Freshner B, Shelton S, Shen T, Black D, Gahtan E. Selective toxicity of L-DOPA to dopamine transporter-expressing neurons and locomotor behavior in zebrafish larvae. Neurotoxicol Teratol. 2015;52:51-56.
Zhong SY, Chen YX, Fang M, Zhu XL, Zhao YX, Liu XY. Low-dose levodopa protects nerve cells from oxidative stress and up-regulates expression of pCREB and CD39. PLoS ONE. 2014;9:e95387.
Josefsson E, Bergquist J, Ekman R, Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 1996;88:140-146.
Slominski A, Goodman-Snitkoff GG. Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res. 1992;12:753-756.
Singh AP, Sarkar S, Tripathi M, Rajender S. Mucuna pruriens and its major constituent L-DOPA recover spermatogenic loss by combating ROS, loss of mitochondrial membrane potential and apoptosis. PLoS One. 2013;8:e54655.
Xi H, Tao W, Jian Z, et al. Levodopa attenuates cellular apoptosis in steroid-associated necrosis of the femoral head. Exp Ther Med. 2017;13:69-74.
Cheng N-N, Maeda T, Kume T, et al. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 1996;743:278-283.
Maeda T, Cheng N-N, Kume T, et al. L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons. Brain Res. 1997;771:159-162.
Al-Azzawi H, Yacqub-Usman K, Richardson A, Hofland LJ, Clayton RN, Farrell WE. Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology. 2011;152:364-373.
Rowther FB, Richardson A, Clayton RN, Farrell WE. Bromocriptine and dopamine mediate independent and synergistic apoptotic pathways in pituitary cells. Neuroendocrinology. 2010;91:256-267.
Hornykiewicz O. L-dopa. J Parkinsons Dis. 2017;7:S3-S10